The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global cardiac holter monitor market reached a value of US$ 386 Million in 2020. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A holter monitor is a battery-operated electrocardiography (ECG) device which assists in measuring and recording the heart’s activity for 24 to 48 hours. It comprises a software, which interprets the recorded data and ultimately helps the doctor in determining if the heart is getting adequate oxygen and diagnosing conditions related to irregular cardiac rhythms including arrhythmia, tachycardia and atrial fibrillation. These attributes of holter monitors in confluence with the rising incidences of cardiac issues among individuals are fueling their demand across the globe.
Owing to rapid urbanization, hectic work schedules and increasing consumption of fast food, a rise in the prevalence of cardiac blockages and arrests have been witnessed globally. This has increased the demand for technologically advanced devices that help in diagnosing health problems accurately. Moreover, governments in numerous countries are funding to create more awareness among individuals about different cardiovascular disorders, their prevention and treatment. Further, a significant shift toward minimally invasive diagnostic tools and preventive healthcare devices among individuals is strengthening the market growth. In line with this, manufacturers are introducing innovative and miniaturized products that offer enhanced convenience. For instance, iRhythm Technologies, a digital healthcare company, has introduced Zio Patch which incorporates the holter monitor into a small pedometer-sized device with an adhesive backing. Similarly, DMS Service has developed MyPatch Holter device that weighs less than a pound and can be stuck to the sternum of the patient, thereby eliminating the need for wires.
The report has also analysed the competitive landscape of the market with some of the key players being The ScottCare Corporation, GE Healthcare, Spacelabs Healthcare, Fukuda Denshi Co., Ltd., Nasiff Associates, Inc., Koninklijke Philips N.V., Biomedical Instruments Co., Ltd., Schiller, BTL, LifeWatch AG, Welch Allyn, Nihon Kohden Corporation, Medtronic Plc, Hill-Rom Company, Inc., Mindray Medical International Limited, BPL Medical Technologies, etc.
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at